Our findings suggest that the C allele may modify ARAP1’s function, potentially enhancing β-cell compensation or insulin sensitivity to meet the increased metabolic demands of pregnancy, thereby lowering GDM risk. Here, ARAP1 is linked to gestational diabetes.